Health Condition 1: O94-O9A- Other obstetric conditions, not elsewhere classified
Conditions
Interventions
Intervention1: use of norepinephrine: 4mcg norepinephrine in the treatment of hypotension after spinal anaesthesia in caesarian section
Control Intervention1: use of phenylephrine: 50 mcg of phenyleph
Sponsors
Dr Sanath kumar Jeganathan
Eligibility
Inclusion criteria
Inclusion criteria: ASA II Gestational age between 36 weeks to 40 weeks
Exclusion criteria
Exclusion criteria: Patient not willing for the procedure Contraindication of regional anaesthesia Parturients with placenta previa,preeclampsia,cardiovascular or cerebrovascular disease allergic reaction to local anesthetics BMI > 30kg/m2 Parturient height < 145cm or 170 cm
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| changes in maternal blood pressure after administration of the drugsTimepoint: To check side effects like bradycardia,reactive hypotension,nausea,vomiting for every 3 min | — |
Primary
| Measure | Time frame |
|---|---|
| To compare the number of bolus doses between norepinephine and phenylephrine in treating intraoperative hypotension after spinal anaesthesiaTimepoint: To compare the number of bolus doses between norepinephine and phenylephrine in treating intraoperative hypotension after spinal anaesthesia for every 3 min | — |
Countries
India
Contacts
Public ContactDr Hemalatha S
JSS Hospital
Outcome results
None listed